AECOM Misses Big: Revenue Down 14.2%, Adjusted EPS Loss, Guidance Slashed—Investors Brace for Impact

What happened

AECOM reported quarterly revenue down 14.2% year over year and an adjusted EPS loss of roughly $0.50, far below consensus estimates of $1.46 to $1.51, while cutting full-year adjusted EPS guidance to approximately $4.05 at the midpoint. The results triggered a sharp decline in the company's shares and prompted Levi & Korsinsky to notify investors of a pending investigation into securities claims related to AECOM. This outcome sharply contradicts the high-quality, capital-light narrative previously presented, where AECOM had record margins, strong free cash flow, and a deep backlog. The master report had already flagged rich valuation multiples and limited margin of safety at ~$98/share, recommending a WAIT stance with specific triggers for downgrade. This earnings miss and guidance cut represent a clear violation of those triggers, signaling potential fundamental deterioration beyond a simple cyclical dip.

Implication

For current holders, the margin of safety has evaporated as the stock price likely falls further, and the elevated multiple can compress rapidly when growth expectations are shattered. The investigation adds legal and reputational risk that can further pressure the stock, regardless of the ultimate outcome. For potential buyers, this could eventually create an entry point if the company can stabilize and demonstrate that the issues are one-time, but until then, knife-catching is dangerous. The trigger for a possible ‘POTENTIAL BUY’ in the master report was sustained growth and delivery of guidance; this quarter directly contradicts that, suggesting a move toward ‘POTENTIAL SELL’ or even outright avoidance. Monitoring the next few quarters for evidence of stabilization, backlog quality, and cash generation will be critical before considering any re-entry.

Thesis delta

The previous WAIT stance was predicated on high quality but rich valuation, with specific triggers for downgrade: a material earnings miss or weakening guidance. This quarter's revenue decline, adjusted EPS loss, and guidance cut directly trigger those conditions, suggesting the company's fundamentals are deteriorating faster than anticipated. The investment thesis shifts from a hold to a likely sell/avoid, as the premium valuation no longer has support from the growth trajectory, and the legal investigation introduces additional downside risk.